Home > Healthcare & Medical Devices > In vitro Diagnostics Market

In vitro Diagnostics Market Size By Product Type (Reagents & Kits, Instruments), By Test Type (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics), By End-user (Hospital, Diagnostic Laboratories, Academic & Research Institutes), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

  • Report ID: GMI2820
  • Base Year: 2020
  • Report Format: PDF

Industry trends

In Vitro Diagnostics Market size exceeded USD 70 billion in 2020 and is projected to grow at a CAGR of 4.9% from 2021 to 2027. Rising incidence of infectious and chronic disease and growing demand for personalized medicines are some of the major factors that facilitate the market growth. Also, increasing adoption of point of care testing is likely to fuel the market progression.
 

In Vitro Diagnostics Market Overview

Get more details on this report - Request Free Sample PDF
 

Moreover, COVID-19 impact on the overall business is observed to be positive as the demand for diagnostic products such as PCR, NGS, serology based rapid-test products witnessed sharp rise. Furthermore, during the COVID-19 pandemic, R&D activities have increased, and FDA granted emergency usage for various in vitro diagnostic tests.
 

Rising prevalence of infectious and chronic diseases worldwide will accelerate the market expansion

Growing prevalence of infectious and chronic diseases globally is one of the major factors driving the industry growth. Infectious diseases are some of the major causes of death in countries across the world. According to WHO reports, nearly 1.5 million people died from tuberculosis in 2020 making it the second leading infectious disease leading to death after COVID-19. Similarly, over 37 million people across the world were living with HIV by December 2020 and globally, about 680,000 people died due to HIV related causes in 2020.
 

The prevalence of such infectious diseases in increasing each year. Such rising cases of infectious disease have created demand for in vitro diagnostic tests, devices, and consumables. Additionally, development of miniaturized diagnostic systems has gained popularity as these nano diagnostic devices enable more rapid and accurate medical diagnosis. In addition, these are disposable, inexpensive, portable, and easy-to-use devices that will aid the industry progression.
 

Growing demand for diagnostic instruments with boost in vitro diagnostics market

The instruments segment is poised to showcase 4.5% growth rate through 2027 owing to increased usage of diagnostic instruments. High accuracy and functionality provided by IVD instruments will increase its demand in the coming years. Also, the rapid investments offered by public and private sectors for the development of diagnostic laboratories in emerging economies, and growing product launches will augment the industry expansion. The continuous development in diagnostic instruments for accurate diagnostic outcomes will influence the business growth.
 

Increased demand for advanced molecular diagnostic tests during COVID-19 pandemic has propelled the segment demand

In Vitro Diagnostics Market Size

Get more details on this report - Request Free Sample PDF
 

The molecular diagnostics segment valued at USD 16 billion in 2020 led by its growing demand in diagnosis of chronic diseases such as cancer as well as infectious diseases such as COVID-19. Also, the increased demand for genomic information has led in rapid expansion of molecular diagnostic tests. Furthermore, availability of advanced tests such as multiplex real time PCR has increased the demand for molecular diagnostics. Multiplex real time PCR test offers high sensitivity and specificity and has ability to detect several pathogens in single sample. Increased availability and growing adoption of molecular diagnostic tests will influence the segment growth.
 

Rising prevalence of cardiovascular diseases worldwide to foster the cardiology segment value

Cardiology segment in the in vitro diagnostics market captured USD 8.8 billion in 2020 impelled by the increasing prevalence of cardiovascular diseases. Heart attacks and strokes were responsible for 85% of these fatalities. Growing cardiovascular diseases along with growing awareness about early diagnosis has led to growth in diagnostic testing numbers. Increasing patient population undergoing early cardiovascular disease diagnosis will further stimulate the overall market revenue.
 

Presence of advanced and innovative equipment will support the diagnostic laboratories market value

The diagnostic laboratories segment accounted for 43% of the market share in 2020 propelled by the high number of diagnostic procedures performed in diagnostic laboratories. Also, presence of advanced technology and instruments in these labs helps in obtaining absolute accuracy. Besides this, the most complex and sensitive diagnostic procedures are performed in laboratories by the skilled staff to minimize the chances of error. Furthermore, with rapid growing healthcare sector, the number of diagnostic laboratories has also increased thereby augmenting its industry demand.
 

Increasing prevalence of chronic diseases in North America to spur the market growth

North America In Vitro Diagnostics Market

Get more details on this report - Request Free Sample PDF
 

North America in vitro diagnostics market held for 42% of revenue share in 2020 owing to the rising expenditure on healthcare, presence of well-established healthcare industry and surging prevalence of chronic diseases the region. For instance, according to the American Cancer Society, in 2020, around 1.8 million new cancer cases were diagnosed in the U.S., with 606,520 cancer deaths. Also, those with chronic illnesses are the most frequent visitors of healthcare facilities in the region for hospital admissions and prescription fillings, thus fueling the market development. In addition, the increasing number of new products launches as well as the high penetration of key market competitors in North America are further driving the market.
 

Presence of numerous companies will boost the market expansion

Some of the prominent players operating in the market include, F. Hoffmann-La Roche AG, Abbott, Danaher, Siemens Healthineers, BioMerieux, DiaSorin, Becton Dickinson and Company, Bio-Rad Laboratories, Qiagen, Ortho Clinical Diagnostics, Sysmex Corporation, and Thermo Fisher Scientific. These market participants are implementing various growth strategies to sustain competition.
 

The market research report in the in vitro diagnostics includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product Type, 2016-2027 (USD Million)

  • Reagents & kits
  • Instruments

Market, By Test Type, 2016-2027 (USD Million)

  • Clinical chemistry
  • Immunoassay/immunochemistry
  • Molecular diagnostics
  • Hematology
  • Urinalysis
  • Others

Market, By Application, 2016-2027 (USD Million)

  • Oncology
  • Infectious diseases
  • Diabetes
  • Cardiology
  • Nephrology
  • Autoimmune diseases
  • Drug testing/pharmacogenomics
  • Others

Market, By End-user, 2016-2027 (USD Million)

  • Hospitals
  • Diagnostic laboratories
  • Academic & research institutes 
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Market size of in vitro diagnostics surpassed USD 70 billion in 2020 and will expand at a CAGR of 4.9% between 2021 and 2027 owing to surging incidence of chronic and infectious diseases and the increasing demand for personalized medicines.

The instruments are anticipated to grow at a rate of 4.5% from 2021 to 2027 considering the benefits of high accuracy and functionality.

The molecular diagnostics accounted for USD 16 billion in 2020 and will expand due to the soaring demand for genomic information and the availability of advanced tests.

North America market recorded 42% of revenue share in 2020 and will grow with the mounting expenditure on healthcare and the rising prevalence of chronic diseases in the region.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Published Date: Nov 2021
  • Companies covered: 12
  • Tables & Figures: 132
  • Countries covered: 17
  • Pages: 160

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount